1 in every 200 people may need to use his or her stem cells in a lifetime.
60% higher chance of locating a matching cord blood unit in the family versus bone marrow.
1 of the top 10 common cancers in India, Non-Hodgkin’s lymphoma, is a stem cell treatable disease.
2 of the top 5 most common childhood cancers in India, leukaemia and lymphoma, are treatable with stem cells.
In the case of cellular therapy and regenerative medicine, only the patient’s own stem cells can be used in the treatment for best result. Clinical trial for Autism is the latest development.
A readily available supply of stored haematopoietic stem cells. This compares well to having to do a national or international search which costly and time-consuming in an already critical situation.
No risk of Graft vs. Host Disease (GvHD) for autologous transplanted tissue attacks the patient’s own tissue.
Umbilical cord blood stem cells are younger, and are more tolerant to tissue mismatches, compared to other sources of stem cells, e.g. bone marrow.